Showing results (81-90 of 179) with videos related to

Sort By:
Pageof 18
International Journal of Clinical Oncology|July 28, 2017
Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasisIzuma Nakayama, Keisho Chin, Tomohiro Matsushima, et al.
Annals of Surgical Oncology|May 4, 2023
Clinical Efficacy of Neoadjuvant Chemotherapy with Gemcitabine plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma Compared with Upfront SurgeryYuki Kitano, Yosuke Inoue, Tsuyoshi Takeda, et al.
International Journal of Cancer|November 19, 2016
Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patientsMotoki Miyazawa, Masahiro Katsuda, Hiroyuki Maguchi, et al.
Internal Medicine (Tokyo, Japan)|March 1, 2022
Multiple Gastric Metastases after Distal Pancreatectomy for Pancreatic CancerYuto Yamada, Takashi Sasaki, Tsuyoshi Takeda, et al.
Oncotarget|April 11, 2018
Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxelNaoki Fukuda, Daisuke Takahari, Takeru Wakatsuki, et al.
Japanese Journal of Clinical Oncology|December 5, 2025
Changing treatment outcomes in metastatic and recurrent pancreatic cancer: a real-world comparison before and after the availability of nanoliposomal irinotecanTakafumi Mie, Masato Ozaka, Takeshi Okamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2010
[Successful treatment with cetuximab combination chemotherapy in a case of FOLFOX-refractory rectal cancer with previously unresectable multiple liver metastases leading to complete resection]Kenjiro Mitsuhashi, Satoshi Matsusaka, Nobuyuki Mizunuma, et al.
BMC Cancer|May 22, 2020
Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancerMasashi Sawada, Akiyoshi Kasuga, Takafumi Mie, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 5, 2018
Protocol digest of randomized phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel combination therapy for locally advanced pancreatic cancer: Japan clinical oncology group study (JCOG1407)Junki Mizusawa, Akira Fukutomi, Hiroshi Katayama, et al.
International Journal of Molecular Sciences|February 15, 2022
Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic CancerAkiyoshi Kasuga, Takeshi Okamoto, Shohei Udagawa, et al.
Pageof 18